Perrigo Grows Into Adjacent Infant Formula Category With PBM Acquisition
This article was originally published in The Tan Sheet
Perrigo takes the next step toward becoming a one-stop shop for private-label consumer health products with its $808 million acquisition of infant formula and baby food firm PBM Holdings Inc
You may also be interested in...
Acura delays Nexafed post meth studies
Private label giant Perrigo is readying generic competitors to Reckitt Benckiser’s Mucinex and Takeda Pharmaceuticals’ Prevacid, CEO Joseph Papa says.
A disciplined growth strategy enables Mead Johnson Nutrition to expand its footprint in China and other emerging markets, as lower U.S. birth rates continue to dampen the firm's domestic business.